Author(s): Brenner MK
Abstract Share this page
Abstract Cellular therapies for cancer are showing increasing efficacy but their introduction as a 'standard of care' for these disorders is hampered by technical, regulatory and financial concerns. This review identifies some of the major problems and suggests potential solutions.
This article was published in Cancer Gene Ther
and referenced in Journal of Clinical & Cellular Immunology